Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Henry, IL

Clayton O. Henry, North Chicago, IL US

Patent application numberDescriptionPublished
20110084109AUTOMATIC LOW POWER CONSUMPTION MODE FOR COMBUSTION TOOLS - A combustion tool having a circuit for conserving battery power includes a battery assembly to power at least a portion of the combustion tool, a control circuit to place the combustion tool in an active mode or a low power consumption mode, and a motion sensing circuit to indicate a movement of the combustion tool and to indicate a non-movement of the combustion tool. A timer is set when a movement is detected and resets each time a new movement is sensed. If a new movement is not sensed when a predetermined amount of time has elapsed, the combustion tool enters into a low power consumption mode. The movement may be a vibration or a tilt movement. The motion sensing circuit enables the tool to be actuated without any unnecessary priming when motion is sensed and only minimal current is consumed when motion is not sensed, conserving battery power.04-14-2011

Francois Henry, Oak Park, IL US

Patent application numberDescriptionPublished
20080248308METHOD OF MAKING GRAPHITE-COATED PARTICULATE MATERIALS - An coated particulate is provided with a graphite-impregnated resin coating. The oil field particulates may comprise any of gravel-pack sand, granular betonite, ground Gilsonite, calcium carbonate, glass beads, rock wool, shredded paper, metal spheres, ceramic beads, nut hulls, ground rubber, plastic beads, muscovite mica, calcined petroleum coke, and perlite. The resin may comprise as a binder one or more of a natural, synthetic, water-soluble, and organic resins. More specifically, the resins may comprise an organic film-forming resin such as an alkyd, polyurethane and epoxy. Alternatively, the resin may comprise a film-forming water-soluble polymer, such as a starch, carboxymethyl cellulose, hydroxyethyl cellulose, and xanthan gum. In a further alternative, the resin may comprise a resin-dispersed emulsion, such as a latex or acrylic.10-09-2008

Kevin Henry, Peoria, IL US

Patent application numberDescriptionPublished
20100318031External Stylette Needle and Method of Use - An external stylette needle device for use in medical/surgical procedures to reduce the introduction of air into a patient and method of use comprising a stylette sizably fit over at least a portion of the exterior surface of a hollow core needle shaft such that the stylette can slide about the needle shaft. The needle having a proximal end including a hub and a distal end including a tip and a distal orifice, the needle further comprising a proximal orifice adjacent the hub. The stylette being further adapted to alternately and reversibly close or open the needle distal orifice and the needle proximal orifice. The device may include an electromagnetic charge to ensure that the stylette remains in contact with the external surface of the needle.12-16-2010

Lamar Steven Henry, Aurora, IL US

Patent application numberDescriptionPublished
20110068186Broadcast\widecast pattern lawn watering implement - A handheld, lightweight method of transferring the water column from a standard garden hose into a time saving and water saving broadcast and/or spray pattern.03-24-2011

Michael P. Henry, Batavia, IL US

Patent application numberDescriptionPublished
20090093556Electronically and ionically conductive porous material and method for manufacture of resin wafers therefrom - An electrically and ionically conductive porous material including a thermoplastic binder and one or more of anion exchange moieties or cation exchange moieties or mixtures thereof and/or one or more of a protein capture resin and an electrically conductive material. The thermoplastic binder immobilizes the moieties with respect to each other but does not substantially coat the moieties and forms the electrically conductive porous material. A wafer of the material and a method of making the material and wafer are disclosed.04-09-2009
20100093049Biological methane production from coal, manure, sludge, wastes, or other carbonaceous feedstocks with simultaneous sequestration of co2 - The present invention provides a method for generating methane from a carbonaceous fuel source with simultaneous sequestration of carbon dioxide, the method comprising anaerobically incubating a particulate alkaline earth metal salt in contact with a particulate and/or dissolved carbonaceous feedstock in a neutral or alkaline aqueous culture medium containing a culture of methanogenic bacteria consortia and collecting methane generated therefrom. At least a portion of carbon dioxide produced during the incubation reacts with the alkaline earth metal salt to form an alkaline earth metal carbonate, thereby sequestering the carbon dioxide.04-15-2010

Patent applications by Michael P. Henry, Batavia, IL US

Robert E. Henry, Napperville, IL US

Patent application numberDescriptionPublished
20110214763CARTRIDGE TYPE VORTEX SUPPRESSION DEVICE - A vortex suppression device is provided which includes a plurality of spaced apart porous panels arranged generally parallel with respect to each other for placement adjacent a suction pipe inlet. The panels of the suppression device are oriented generally perpendicular to, or parallel to the suction pipe inlet. The device serves to prevent formation of a sufficiently strong vortex capable of pulling a continuous gas core into the suction piping.09-08-2011

Rodger Henry, Wildwood, IL US

Patent application numberDescriptionPublished
20100261703SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG - A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.10-14-2010
20100286397SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG - A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.11-11-2010
20100305125SALT OF ABT-263 AND SOLID-STATE FORMS THEREOF - ABT-263 bis-HCl and crystalline polymorphs thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.12-02-2010
20110009325CRYSTALLINE FORMS OF RAPAMYCIN ANALOGS - Provided is a rapamycin analog composition including a crystalline form of a rapamycin analog. The crystal can be a hydrate. dehydrate, solvate, or desolvate. The rampamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof:01-13-2011
20110009618METHODS OF MANUFACTURING CRYSTALLING FORMS OF RAPAMYCIN ANALOGS - A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split.01-13-2011

Patent applications by Rodger Henry, Wildwood, IL US

Rodger F. Henry, Wildwood, IL US

Patent application numberDescriptionPublished
20090105326Crystalline Chemotherapeutic - N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea·¼ Ethanolate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it is disclosed.04-23-2009
20090105486Crystalline Chemotherapeutic - N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5-methylphenyl)urea Tolueneate Crystalline Form 1, ways to make it and ways to use it are disclosed.04-23-2009
20090176784ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.07-09-2009
20090203664(1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6- DIAZABICYCLO[3.2.0]HEPTANE - The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.08-13-2009
20100048533LESTAURTINIB CRYSTALLINE FORM 1, CRYSTALLINE LESTAURIMIB ANHYDRATE AND AMORPHOUS LESTAURIMIB - Lestaurtinib Crystalline Form 1, isolated crystalline lestaurtinib anhydrate and amorphous lestaurtinib, processes to reproducibly make them and methods of treating patients using them.02-25-2010
20100048534CRYSTALLINE LESTAURTINIB HYDRATES AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMIACETONITRILEATE AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMITETRAHYDROFURANATE - Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemicetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate, processes to reproducibly make them and methods of treating patients using them are disclosed.02-25-2010
20100222358OCTAHYDRO-PYRROLO[3,4-B]PYRROLE DERIVATIVES - Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.09-02-2010

Patent applications by Rodger F. Henry, Wildwood, IL US

Thomas Henry, Mchenry, IL US

Patent application numberDescriptionPublished
20090074939STABLE MEAT PRODUCT FOR A FOOD ENVIRONMENT AND A METHOD OF MAKING SUCH A PRODUCT - The present invention is directed to a stable meat product and method of making such a product by mixing a raw communicated meat with a salt mix and a carotenoid stabilizing composition to form a complex that after thermal processing allows the meat product to retain its interior and exterior color, flavor, and/or texture during storage in a food composition.03-19-2009
20090285942COLOR STABLE MEAT PRODUCT FOR AN EGG PRODUCT - The present invention is directed to a color stable meat product for storage in an egg product and the method of making such products by adding a color agent to a raw meat or by adding a color coating to a processed and/or cooked meat.11-19-2009

Patent applications by Thomas Henry, Mchenry, IL US

Todd Henry, Dixon, IL US

Patent application numberDescriptionPublished
20080247595Electromagnetic lever diaphragm audio transducer - An electromagnetic transducer including a frame, a diaphragm disposed within the frame and coupled to the frame such that the diaphragm may rotate relative to the frame, a panel-shaped former connected to the diaphragm, a conductive coil connected to the former, and a magnetic assembly including a gap in which a magnetic field is provided. The gap is positioned to receive the conductive coil, and the conductive coil is electrically charged within the gap to move such that the diaphragm rotates about a rotational axis to generate sound waves.10-09-2008

Todd R. Henry, Arlington Heights, IL US

Patent application numberDescriptionPublished
20090309786Synthetic aperture radar system - An imaging system for generating a three dimensional image of tissue of a patient is provided. The imaging system comprises of a transmitter, receiver, antenna system and a display element to form a synthetic aperture radar system that displays a three dimensional view of the tissue. The SAR system has been configured to operate in the near field as opposed to current equipment which can only perform satisfactorily in the far field. A calibration technique has been utilized that allows the system to perform as well as other systems that operate using far field techniques but allows for a much simpler, cost effective system.12-17-2009

Tricia Ehlers Henry, Bartlett, IL US

Patent application numberDescriptionPublished
20090257570System and Method for Accessing a Messaging Service Using a Short Dialing Sequence - A system and method for providing easy access to messaging services in a telecommunications network having office switches that are used by different providers of telephone and messaging services. The system uses a supplementary services database to maintain customer records including whether the customer uses messaging services and whether the customer subscribes to a short dialing sequence service for access to the messaging services. The customer is connected to the central office switch, which analyzes the dialing sequences generated by the customer. When the customer attempts access to the messaging services, the customer dials a short dialing or message sequence, such as *XX. The central office switch triggers a query to the supplementary services database for a call forwarding number to the messaging service used by the customer when the selected short dialing sequence is recognized by the switch. When the central office switch receives the call forwarding number, the number is used to route the customer to the messaging service.10-15-2009